For patients with cardiogenic shock transferring from a referring hospital, the median time to acceptance fell from 1.55 hours to 0.35 hours. The analysis indicated no differences in mortality ...
An important cohort of patients who might be expected to derive maximum benefit from angioplasty comprises patients presenting with MI complicated by cardiogenic shock. However, in the recently ...
and results pertaining to all-cause mortality (ACM), cardiogenic shock (CS), length of stay (LOS), and hospitalization expense. Moreover, propensity score matching was conducted in a 1:1 ratio ...
Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...